Align Technologies

Align Technologies

Price: 170.50

Company and Business Model

Align Technologies is a healthcare company specializing in digital orthodontics and dental solutions. Its core products include the Invisalign clear aligner system and iTero intraoral scanners. The company primarily generates revenue through the sale of these products and associated services, targeting both dental professionals and consumers. Align operates in the orthodontics and restorative dentistry segments, focusing on innovation and technology to enhance patient outcomes.

Investment Profile

Align Technologies presents a neutral investment profile, appealing to investors seeking growth due to its innovative product offerings and market position. However, the company's recent revenue decline and elevated risk factors suggest caution. This stock may be suitable for balanced investors looking for a mix of growth potential and stability.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
5.97 OK
Revenue QoQ — quarter-over-quarter revenue growth
-0.7%
EPS surprise
14.2% better than expected
20d volatility
2.6% stable
FMP / FinFeed data updated: 2026-06-10
Reco: Hold Potential: 62 Risk: 51 Updated: 2026-06-11 05:35
How recommendation works
Why AI thinks so:
Mixed performance; cautious outlook amid market uncertainty.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-05-08 15:10 Hold Weak momentum and fundamentals raise significant risk concerns.
2026-05-08 05:36 Hold Hold Компания показывает смешанные результаты, с недавним снижением цен, но с положительной динамикой за 120 дней. Рекомендуется держать акции до получения более ясных сигналов о восстановлении.
2026-05-01 02:57 Buy Hold Компания показывает положительную динамику на длительном горизонте, однако недавние колебания цен и снижение выручки в квартальном выражении вызывают опасения.
Analyst forecasts
Date Analyst Action Target Price Then
2026-04-24 11:41 Morgan Stanley Target Raised 169 → 188 190.67
2026-04-21 11:01 Piper Sandler Target Raised 220 → 235 191.66
2026-02-25 18:30 Barclays Target Raised 170 → 200 187.68
Align Technologies

Аналитики Barclays повысили рейтинг Align Technologies (ALGN), ожидая роста акций на 18% на фоне конфликта в Ближнем Востоке

Barclays считает, что недавнее снижение акций Align Technologies, связанное с напряженностью на Ближнем Востоке, улучшило соотношение риска и вознаграждения для инвесторов.